Historical record - last NADAC publication: 6/19/2024

Product Information

MUCINEX FAST-MAX COLD-FLU LIQ is a brand product labeled by RB Health (US) LLC, priced at $0.0621 per ML under NDC 63824052703. Its NADAC has been published 177 times since Oct 9, 2019.

The High Outlier badge above means this manufacturer's average price in the ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

High Outlier
OTC

Strength

650; 20; 400; 10 mg/20mL; mg/20mL; mg/20mL; mg/20mL

Manufacturer

RB Health (US) LLC

NDC

63824052703

Classification

Brand

Dosage Form

SOLUTION

Route

ORAL

Last Updated

6/19/2024

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M012

On Market Since

7/28/2018

Pharmacological Classes

Adrenergic alpha1-Agonists
Decreased Respiratory Secretion Viscosity
Expectorant
Increased Respiratory Secretions
Sigma-1 Agonist
Sigma-1 Receptor Agonists
Uncompetitive N-methyl-D-aspartate Receptor Antagonist
Uncompetitive NMDA Receptor Antagonists
alpha-1 Adrenergic Agonist

Price Statistics

The NADAC for MUCINEX FAST-MAX COLD-FLU LIQ has been published 177 times since Oct 9, 2019, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.0621 per ML
All-time high$0.0670 (Jun 29, 2022)
All-time low$0.0570 (Nov 15, 2023)
Median price$0.0593
Average price$0.0601
Largest weekly change-15.0% (Nov 15, 2023)
Weeks tracked177
Tracking sinceOct 9, 2019

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

-7.2%

5Y

0.0%

All

-1.4%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of MUCINEX FAST-MAX COLD-FLU LIQ?

The current National Average Drug Acquisition Cost (NADAC) for MUCINEX FAST-MAX COLD-FLU LIQ, manufactured by RB Health (US) LLC, is $0.0621 per ML (NDC 63824052703), effective Jul 3, 2024.

How has the price of MUCINEX FAST-MAX COLD-FLU LIQ changed over time?

Over the history we have for it, the NADAC for MUCINEX FAST-MAX COLD-FLU LIQ has held within roughly two percent of its current level. It has been tracked across 177 weekly CMS publications since Oct 9, 2019.

What are the highest and lowest recorded NADAC prices for MUCINEX FAST-MAX COLD-FLU LIQ?

Since Oct 9, 2019, the NADAC for MUCINEX FAST-MAX COLD-FLU LIQ has ranged from a low of $0.0570 (Nov 15, 2023) to a high of $0.0670 (Jun 29, 2022), with a median of $0.0593 per ML.

Are there cheaper alternatives to MUCINEX FAST-MAX COLD-FLU LIQ?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of MUCINEX FAST-MAX COLD-FLU LIQ, so no direct lower-cost alternative is listed.

Who manufactures MUCINEX FAST-MAX COLD-FLU LIQ?

MUCINEX FAST-MAX COLD-FLU LIQ (NDC 63824052703) is labeled by RB Health (US) LLC, and CMS classifies it as a brand product.